These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Molecular Mechanisms of Azole Resistance in Four Clinical Candida albicans Isolates. Shi H, Zhang Y, Zhang M, Chang W, Lou H. Microb Drug Resist; 2021 Dec; 27(12):1641-1651. PubMed ID: 34037478 [Abstract] [Full Text] [Related]
67. SAGA/ADA complex subunit Ada2 is required for Cap1- but not Mrr1-mediated upregulation of the Candida albicans multidrug efflux pump MDR1. Ramírez-Zavala B, Mogavero S, Schöller E, Sasse C, Rogers PD, Morschhäuser J. Antimicrob Agents Chemother; 2014 Sep; 58(9):5102-10. PubMed ID: 24936593 [Abstract] [Full Text] [Related]
72. Evidence that Ergosterol Biosynthesis Modulates Activity of the Pdr1 Transcription Factor in Candida glabrata. Vu BG, Thomas GH, Moye-Rowley WS. mBio; 2019 Jun 11; 10(3):. PubMed ID: 31186322 [Abstract] [Full Text] [Related]
75. Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains. Schubert S, Rogers PD, Morschhäuser J. Antimicrob Agents Chemother; 2008 Dec 11; 52(12):4274-80. PubMed ID: 18809934 [Abstract] [Full Text] [Related]
76. Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole. Reis de Sá LF, Toledo FT, Gonçalves AC, Sousa BA, Dos Santos AA, Brasil PF, Duarte da Silva VA, Tessis AC, Ramos JA, Carvalho MA, Lamping E, Ferreira-Pereira A. Antimicrob Agents Chemother; 2017 Jan 11; 61(1):. PubMed ID: 27821447 [Abstract] [Full Text] [Related]
77. Changes in susceptibility to posaconazole in clinical isolates of Candida albicans. Li X, Brown N, Chau AS, López-Ribot JL, Ruesga MT, Quindos G, Mendrick CA, Hare RS, Loebenberg D, DiDomenico B, McNicholas PM. J Antimicrob Chemother; 2004 Jan 11; 53(1):74-80. PubMed ID: 14657086 [Abstract] [Full Text] [Related]